Page last updated: 2024-08-21

quinazolines and 3-aminopyridine-2-carboxaldehyde thiosemicarbazone

quinazolines has been researched along with 3-aminopyridine-2-carboxaldehyde thiosemicarbazone in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Giri, S; Huang, PH; Korayem, Y; Lin, ZP; Lo, YC; LoRusso, P; Moscarelli, J; Ratner, ES; Xiong, A; Zhu, YL	1

Other Studies

1 other study(ies) available for quinazolines and 3-aminopyridine-2-carboxaldehyde thiosemicarbazone

Article	Year
Combination of triapine, olaparib, and cediranib suppresses progression of BRCA-wild type and PARP inhibitor-resistant epithelial ovarian cancer. PloS one, 2018, Volume: 13, Issue:11 Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; BRCA1 Protein; Breast Neoplasms; Cell Line, Tumor; Drug Resistance, Neoplasm; Female; Humans; Mice, Nude; Mice, SCID; Phthalazines; Piperazines; Poly(ADP-ribose) Polymerase Inhibitors; Pyridines; Quinazolines; Thiosemicarbazones; Xenograft Model Antitumor Assays	2018

Article

Year

Combination of triapine, olaparib, and cediranib suppresses progression of BRCA-wild type and PARP inhibitor-resistant epithelial ovarian cancer.

PloS one, 2018, Volume: 13, Issue:11

Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; BRCA1 Protein; Breast Neoplasms; Cell Line, Tumor; Drug Resistance, Neoplasm; Female; Humans; Mice, Nude; Mice, SCID; Phthalazines; Piperazines; Poly(ADP-ribose) Polymerase Inhibitors; Pyridines; Quinazolines; Thiosemicarbazones; Xenograft Model Antitumor Assays

2018